Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 4,877 | 10,256 | 3,110 | 3,811 | 3,680 |
| Operating Income | -4,877 | -10,256 | -3,110 | -3,811 | -3,680 |
| Other Income | 2,007 | 145 | 73 | 95 | 117 |
| Pre-tax Income | -2,870 | -10,111 | -3,037 | -3,716 | -3,563 |
| Net Income Continuous | -2,870 | -10,111 | -3,037 | -3,716 | -3,563 |
| Net Income | $-2,870 | $-10,111 | $-3,037 | $-3,716 | $-3,563 |
| EPS Basic Total Ops | -0.12 | -0.23 | -0.41 | -0.66 | -1.61 |
| EPS Basic Continuous Ops | -0.12 | -0.23 | -0.41 | -0.66 | -1.61 |
| EPS Diluted Total Ops | -0.12 | -0.23 | -0.41 | -0.66 | -1.61 |
| EPS Diluted Continuous Ops | -0.12 | -0.23 | -0.41 | -0.66 | -1.61 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.89 | -0.41 | -0.66 | -1.61 |
| EBITDA(a) | $-4,719 | $-10,099 | $-2,929 | $-3,650 | $-3,518 |